These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11535313)

  • 1. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines.
    Livingston BD; Newman M; Crimi C; McKinney D; Chesnut R; Sette A
    Vaccine; 2001 Sep; 19(32):4652-60. PubMed ID: 11535313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge.
    Daftarian P; Ali S; Sharan R; Lacey SF; La Rosa C; Longmate J; Buck C; Siliciano RF; Diamond DJ
    J Immunol; 2003 Oct; 171(8):4028-39. PubMed ID: 14530323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
    Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
    J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
    McKinney DM; Skvoretz R; Livingston BD; Wilson CC; Anders M; Chesnut RW; Sette A; Essex M; Novitsky V; Newman MJ
    J Immunol; 2004 Aug; 173(3):1941-50. PubMed ID: 15265928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques.
    Fuller DH; Shipley T; Allen TM; Fuller JT; Wu MS; Horton H; Wilson N; Widera G; Watkins DI
    Virology; 2007 Aug; 364(2):245-55. PubMed ID: 17428516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations.
    Yang Y; Sun W; Guo J; Zhao G; Sun S; Yu H; Guo Y; Li J; Jin X; Du L; Jiang S; Kou Z; Zhou Y
    Hum Vaccin Immunother; 2015; 11(3):795-805. PubMed ID: 25839222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen.
    Okazaki T; Pendleton CD; Lemonnier F; Berzofsky JA
    J Immunol; 2003 Sep; 171(5):2548-55. PubMed ID: 12928405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes.
    Bergmann CC; Yao Q; Ho CK; Buckwold SL
    J Immunol; 1996 Oct; 157(8):3242-9. PubMed ID: 8871618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens.
    Rice J; Dunn S; Piper K; Buchan SL; Moss PA; Stevenson FK
    Cancer Res; 2006 May; 66(10):5436-42. PubMed ID: 16707472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.
    Bazhan SI; Belavin PA; Seregin SV; Danilyuk NK; Babkina IN; Karpenko LI; Nekrasova NA; Lebedev LR; Ignatyev GM; Agafonov AP; Poryvaeva VA; Aborneva IV; Ilyichev AA
    Vaccine; 2004 Apr; 22(13-14):1672-82. PubMed ID: 15068850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of multiepitope human leukocyte antigen-A*0201 restricted cytotoxic T-lymphocyte peptide construct against challenge with human T-cell lymphotropic virus type 1 Tax recombinant vaccinia virus.
    Sundaram R; Lynch MP; Rawale S; Dakappagari N; Young D; Walker CM; Lemonnier F; Jacobson S; Kaumaya PT
    J Acquir Immune Defic Syndr; 2004 Nov; 37(3):1329-39. PubMed ID: 15483462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine.
    Singh RA; Wu L; Barry MA
    J Immunol; 2002 Jan; 168(1):379-91. PubMed ID: 11751984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct.
    Cardinaud S; Bouziat R; Rohrlich PS; Tourdot S; Weiss L; Langlade-Demoyen P; Burgevin A; Fiorentino S; van Endert P; Lemonnier FA
    AIDS; 2009 Sep; 23(15):1945-54. PubMed ID: 19644347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
    J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Different systems of delivery of HIV-1 DNA vaccine encoding the multiepitope CTL-immunogene].
    Il'ichev AA; Karpenko LI; Nekrasova NA; Lebedev LR; Ignat'ev GM; Agafonov AP; Belavin PA; Seregin SS; Daniliuk NK; Bazhan SI
    Vestn Ross Akad Med Nauk; 2005; (1):41-4. PubMed ID: 15715155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV vaccine development by computer assisted design: the GAIA vaccine.
    De Groot AS; Marcon L; Bishop EA; Rivera D; Kutzler M; Weiner DB; Martin W
    Vaccine; 2005 Mar; 23(17-18):2136-48. PubMed ID: 15755584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys.
    Subbramanian RA; Kuroda MJ; Charini WA; Barouch DH; Costantino C; Santra S; Schmitz JE; Martin KL; Lifton MA; Gorgone DA; Shiver JW; Letvin NL
    J Virol; 2003 Sep; 77(18):10113-8. PubMed ID: 12941922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.